JP2007106777A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007106777A5 JP2007106777A5 JP2007017195A JP2007017195A JP2007106777A5 JP 2007106777 A5 JP2007106777 A5 JP 2007106777A5 JP 2007017195 A JP2007017195 A JP 2007017195A JP 2007017195 A JP2007017195 A JP 2007017195A JP 2007106777 A5 JP2007106777 A5 JP 2007106777A5
- Authority
- JP
- Japan
- Prior art keywords
- desloratadine
- mometasone furoate
- medicament
- use according
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (10)
- デスロラタジンおよびモメタゾンフロエートの局所適用を含む併用療法により鼻炎を治療するための医薬の製造における、デスロラタジンの使用。
- デスロラタジンおよびモメタゾンフロエートの局所適用を含む併用療法により鼻炎を治療するための医薬の製造における、モメタゾンフロエートの使用。
- 請求項1または請求項2のうちのいずれかに記載の使用であって、前記デスロラタジンおよびモメタゾンフロエートが別個の投薬形状で存在していることを特徴とする、使用。
- 請求項1または請求項2のうちのいずれかに記載の使用であって、前記デスロラタジンおよびモメタゾンフロエートが単位投薬形状で存在していることを特徴とする、使用。
- 請求項1〜4のうちのいずれか1項に記載の使用であって、前記医薬が水性スプレー式点鼻薬の形状であることを特徴とする、使用。
- 請求項1〜4のうちのいずれか1項に記載の使用であって、前記医薬が加圧計量用量吸入器の形状であることを特徴とする、使用。
- 薬学的に受容可能な担体中にデスロラタジンおよびモメタゾンフロエートを含有することを特徴とする、流体組成物。
- 請求項7に記載の組成物であって、前記デスロラタジンおよびモメタゾンフロエートのうちの一方または両方が懸濁した粒子として存在していることを特徴とする、使用。
- 請求項7または請求項8のうちのいずれかに記載の組成物であって、前記担体が水性媒体を含有することを特徴とする、組成物。
- 請求項7または請求項8のうちのいずれかに記載の組成物であって、前記担体が低沸点クロロフルオロカーボン噴霧剤または低沸点フルオロハイドロカーボン噴霧剤を含有することを特徴とする、組成物。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41508399A | 1999-10-08 | 1999-10-08 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001529720A Division JP2003511417A (ja) | 1999-10-08 | 2000-10-05 | 局所的鼻疾患治療 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007295933A Division JP2008056698A (ja) | 1999-10-08 | 2007-11-14 | 局所的鼻疾患治療 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007106777A JP2007106777A (ja) | 2007-04-26 |
JP2007106777A5 true JP2007106777A5 (ja) | 2007-12-27 |
Family
ID=23644317
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001529720A Withdrawn JP2003511417A (ja) | 1999-10-08 | 2000-10-05 | 局所的鼻疾患治療 |
JP2007017195A Pending JP2007106777A (ja) | 1999-10-08 | 2007-01-26 | 局所的鼻疾患治療 |
JP2007295933A Pending JP2008056698A (ja) | 1999-10-08 | 2007-11-14 | 局所的鼻疾患治療 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001529720A Withdrawn JP2003511417A (ja) | 1999-10-08 | 2000-10-05 | 局所的鼻疾患治療 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007295933A Pending JP2008056698A (ja) | 1999-10-08 | 2007-11-14 | 局所的鼻疾患治療 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1227812B1 (ja) |
JP (3) | JP2003511417A (ja) |
AR (1) | AR025964A1 (ja) |
AT (1) | ATE359784T1 (ja) |
AU (1) | AU7859800A (ja) |
CA (1) | CA2383970A1 (ja) |
DE (1) | DE60034476T2 (ja) |
ES (1) | ES2284531T3 (ja) |
WO (1) | WO2001026658A2 (ja) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003101434A2 (en) * | 2001-12-21 | 2003-12-11 | Sampad Bhattacharya | Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
TR200201343A2 (tr) * | 2002-05-17 | 2003-12-22 | Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Kortikosteroid ve antiseptik içeren farmasötik bileşim |
EP1560586A1 (en) * | 2002-11-12 | 2005-08-10 | Alcon, Inc. | The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
CA2518960C (en) | 2003-03-14 | 2013-08-27 | Sinexus, Inc. | Sinus delivery of sustained release therapeutics |
WO2004082589A2 (en) * | 2003-03-20 | 2004-09-30 | Ranbaxy Laboratories Limited | Nasally administrable, bioavailable pharmaceutical composition of loratadine |
TW200522932A (en) * | 2003-09-15 | 2005-07-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
WO2006058022A1 (en) | 2004-11-24 | 2006-06-01 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
CA2603081C (en) | 2005-04-04 | 2013-09-03 | Sinexus, Inc. | Device and methods for treating paranasal sinus conditions |
US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
WO2008008373A2 (en) | 2006-07-11 | 2008-01-17 | Arubor Corp | Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
DE102006034883A1 (de) * | 2006-07-25 | 2008-01-31 | Hermal Kurt Herrmann Gmbh & Co. Ohg | Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat |
US20090325917A1 (en) * | 2006-10-19 | 2009-12-31 | Cipla Limited | Pharmaceutical Compositions and Nasal Spray Incorporating Anhydrous Mometasone Furoate |
AU2008338586B2 (en) | 2007-12-18 | 2015-01-29 | Intersect Ent, Inc. | Self-expanding devices and methods therefor |
WO2010014834A1 (en) | 2008-08-01 | 2010-02-04 | Sinexus, Inc. | Methods and devices for crimping self-expanding devices |
KR101099826B1 (ko) | 2009-02-16 | 2011-12-27 | 서울대학교산학협력단 | 항알러지성 약물을 활성성분으로 함유하는 비강투여용 액상제제 |
EP3103502A1 (en) | 2009-05-15 | 2016-12-14 | Intersect ENT, Inc. | Expandable devices and methods therefor |
WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
FR2970180B1 (fr) * | 2011-01-06 | 2013-08-02 | Substipharm Dev | Procede de preparation de suspensions aqueuses pharmaceutiques comprenant un medicament efficace dans le traitement des rhinites |
DE112011105633T5 (de) | 2011-09-21 | 2014-08-28 | Mitsubishi Electric Corp. | Siliziumkarbidhalbleitervorrichtung und Verfahren zu ihrer Herstellung |
AU2014236729B2 (en) | 2013-03-14 | 2018-11-22 | Intersect Ent, Inc. | Systems, devices, and method for treating a sinus condition |
US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
EP3043773B1 (en) | 2013-09-13 | 2021-06-30 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine for nasal administration |
US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
CN105792828A (zh) | 2013-10-04 | 2016-07-20 | 格兰马克药品有限公司 | 使用莫米松和奥洛他定的组合治疗过敏性鼻炎 |
US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
US20160120928A1 (en) * | 2014-11-03 | 2016-05-05 | Zent, Inc. | Nasal spray |
ES2802530T3 (es) * | 2015-08-04 | 2021-01-20 | Windstar Medical Gmbh | Una composición nasal |
CN106619504A (zh) * | 2016-11-10 | 2017-05-10 | 北京万全德众医药生物技术有限公司 | 一种地氯雷他定口服滴剂及其制备方法 |
CN111787954B (zh) * | 2018-02-23 | 2023-09-05 | 格兰马克专业公司 | 使用莫美他松和奥洛他定的组合治疗儿科受试者的过敏性鼻炎 |
JP7337791B2 (ja) * | 2018-06-22 | 2023-09-04 | 参天製薬株式会社 | デスロラタジン又はその塩を含有する医薬組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE246497T1 (de) * | 1991-06-10 | 2003-08-15 | Schering Corp | Fluorchlorkohlenwasserstoffreie aerosolformulierungen |
PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
EP0780127A1 (en) * | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
CA2256721A1 (en) * | 1996-06-04 | 1997-12-11 | The Procter & Gamble Company | A nasal spray containing an intranasal steroid and an antihistamine |
US5939426A (en) * | 1997-02-28 | 1999-08-17 | Sepracor Inc. | Methods for treating urinary incontinence using descarboethoxyloratadine |
JP2001510485A (ja) * | 1999-03-01 | 2001-07-31 | シェーリング コーポレイション | アトピー性皮膚炎、血管性浮腫および他の障害を抗ヒスタミン薬およびグルココルチコイドを用いて処置するための組成物および方法 |
-
2000
- 2000-10-05 ES ES00968725T patent/ES2284531T3/es not_active Expired - Lifetime
- 2000-10-05 AR ARP000105256A patent/AR025964A1/es unknown
- 2000-10-05 AT AT00968725T patent/ATE359784T1/de not_active IP Right Cessation
- 2000-10-05 WO PCT/US2000/027463 patent/WO2001026658A2/en active IP Right Grant
- 2000-10-05 CA CA002383970A patent/CA2383970A1/en not_active Abandoned
- 2000-10-05 JP JP2001529720A patent/JP2003511417A/ja not_active Withdrawn
- 2000-10-05 AU AU78598/00A patent/AU7859800A/en not_active Abandoned
- 2000-10-05 DE DE60034476T patent/DE60034476T2/de not_active Expired - Lifetime
- 2000-10-05 EP EP00968725A patent/EP1227812B1/en not_active Expired - Lifetime
-
2007
- 2007-01-26 JP JP2007017195A patent/JP2007106777A/ja active Pending
- 2007-11-14 JP JP2007295933A patent/JP2008056698A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007106777A5 (ja) | ||
JP2010132695A5 (ja) | ||
JP2014530231A5 (ja) | ||
HRP20130835T1 (hr) | Farmaceutske formulacije otopine za davanje kao stlaäśeni inhalat u inhalatoru | |
JP2013224331A5 (ja) | ||
CL2009000601A1 (es) | Composicion farmaceutica inhalable en forma de polvo seco que comprende bromuro de aclidinio y un vehiculo, que proporciona una dosis nominal medida de aclinio equivalente a aproximadamente 200 ug de bromuro de aclinio; su uso en epoc y asma; dispositivo inhalador de polvo seco multidosis. | |
JP2014528470A5 (ja) | ||
JP2011520911A5 (ja) | ||
HRP20151214T4 (hr) | Pripravak za inhalaciju koji sadrži aklidinij za liječenje kronične opstruktivne plućne bolesti | |
ECSP14028814A (es) | Nueva forma de dosificación y formulación de abediterol | |
WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
EA201201397A1 (ru) | Ингалятор, содержащий расслаиваемую блистерную упаковку | |
CL2014003211A1 (es) | Composicion farmaceutica para inhalacion que comprende aclidinio, con lactosa, que proporciona una dosis de 322 ug de base libre y aprox 140 ug de bromuro de aclidinio; un metodo para tratar una afeccion respiratoria seleccionada de asma y epoc; uso de la composicion; y un dispositivo inhalador de polvo seco calibrado que la comprende | |
JP2014504636A5 (ja) | ||
RS53821B1 (en) | INHALATION PHARMACEUTICAL COMPOSITION | |
CY1117596T1 (el) | Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης | |
JP2014520874A5 (ja) | ||
WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
EA201201390A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
CO6270213A2 (es) | Composiciones farmaceuticas que comprenden acido montelukast y un unhibidor depde-4 o un corticoesteroide inhalado para administracion por inhalacion | |
JP2011500731A5 (ja) | ||
JP2015536334A5 (ja) | ||
HRP20221034T1 (hr) | Aklidinij za upotrebu u povećanju fizičke aktivnosti u dnevnom životu kod pacijenta koji pati od kronične opstruktivne bolesti pluća | |
JP2017511307A5 (ja) | ||
JP2015533131A5 (ja) |